Claims
- 1. An antihypertensive compound of the formula: ##STR79## or a pharmaceutically suitable salt thereof, wherein A is a carbon-carbon single bond, CO, O, NHCO, or OCH.sub.2 ;
- R.sup.1 is alkyl of 2 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms, or (CH.sub.2).sub.n OR.sup.4 provided than when R.sup.1 is (CH.sub.2).sub.n OR.sup.4 then R.sup.2 is H, alkyl of 2 to 6 carbon atoms, or alkenyl or alkynyl of 3 to 6 carbon atoms;
- R.sup.2 is H, alkyl of 2 to 6 carbon atoms, alkenyl or alkynyl of 3 or 3 carbon atoms; --(CH.sub.2).sub.n OR.sup.4 ; --(CH.sub.2).sub.m COR.sup.6 ; --(CH.sub.2).sub.n OCOR.sup.4 ; --(CH.sub.2).sub.n S(O).sub.t R.sup.4 ; --(CH.dbd.CH(CH.sub.2).sub.m CR.sup.4 HOR.sup.12 ; --CH.dbd.CH(CH.sub.2).sub.m COR.sup.6 ; --(CH.sub.2).sub.n NHCOOR.sup.11 ; --(CH.sub.2).sub.n NHSO.sub.2 R.sup.11 ; --CH.sub.2).sub.n F; or ##STR80## R.sup.3 is CO.sub.2 H, --NHSO.sub.2 CF.sub.3 ; or ##STR81## R.sup.4 is H or alkyl of 1-4 carbon atoms; R.sup.5 is H, halogen, NO.sub.2, methoxy, or alkyl of 1 to 4 carbon atoms;
- R.sup.4 is H or alkyl of 1-4 carbon atoms;
- R.sup.5 is H, halogen, NO.sub.2, methoxy, or alkyl of 1 to 4 carbon atoms;
- R.sup.6 is H, alkyl of 1 to 6 carbon atoms; cycloalkyl of 3 to 6 carbon atoms, (CH.sub.2).sub.m C.sub.6 H.sub.5, OR.sup.7 or NR.sup.8 R.sup.9 ;
- R.sup.7 is H, alkyl of 1 to 5 carbon atoms; cycloalkyl of 3 to 6 carbon atoms; phenyl or benzyl;
- R.sup.8 and R.sup.9 are independently H, alkyl of 1 to 4 carbon atoms, phenyl, or benzyl; or NR.sup.8 R.sup.9 taken together form a ring of the formula: ##STR82## Q is NR.sup.10, O or CH.sub.2 ; R.sup.10 is H, alkyl of 1 to 10 carbon atoms or perfluoroalkyl of 1 to 6 carbon atoms or (CH.sub.2).sub.p C.sub.6 H.sub.5 ;
- R.sup.12 is H, alkyl of 1 to 4 carbon atoms, or acyl of 1 to 4 carbon atoms;
- m is 0 to 6;
- n is 1 to 6;
- r is 0 to 1;
- t is 0 to 2,
- 2. Compound of claim 1 wherein:
- A is a carbon-carbon single bond or NHCO;
- R.sup.1 is alkyl, alkenyl or alkynyl, each of 3 to 5 carbon atoms;
- R.sup.2 is H, alkyl, alkenyl or alkynyl, each of 3 to 5 carbon atoms; --(CH.sub.2).sub.n OR.sup.4 ; --(CH.sub.2).sub.m COR.sup.6 ; --(CH.sub.2).sub.n OCOR.sup.4 ; --CH.dbd.CH(CH.sub.2).sub.m CR.sup.4 HOR.sup.12 ; --CH.dbd.CHOCH.sub.2).sub.m COR.sup.6 ; --(CH.sub.2).sub.n NHCOOR.sup.11 ; --(CH.sub.2).sub.n NHSO.sub.2 R.sup.11 ; --(CH.sub.2).sub.n F; or ##STR83## R.sup.4 is H or CH.sub.3 ; R.sup.5 is H;
- R.sup.6 is H, alkyl of 1 to 6 carbon atoms; OR.sup.7 or NR.sup.8 R.sup.9 ;
- R.sup.7 is alkyl of 1 to 5 carbon atoms;
- R.sup.8 and R.sup.9 are independently H or alkyl of 1 to 4 carbon atoms; or NR.sup.8 R.sup.9 taken together form a ring of the formula: ##STR84## R.sup.11 is alkyl of 1 to 4 carbon atoms, CF.sub.3 or phenyl; m is 0 to 3;
- n is 1 to 3;
- or a pharmaceutically suitable salt thereof.
- 3. Compound of claim 2 wherein:
- A is a carbon-carbon single bond;
- R.sup.1 is alkyl or alkenyl of 3 to 5 carbon atoms;
- R.sup.2 is alkyl or alkenyl of 3 to 5 carbon atoms; --CH.sub.2 OR.sup.4 ; --COR.sup.6 ; --CH.sub.2 COR.sup.6 ; --CH.sub.2 OCOR.sup.4 ; OR--CH.sub.2 NHCOOR.sup.11 ;
- R.sup.6 is H, alkyl of 1 to 4 carbon atoms or OH;
- or a pharmaceutically suitable salt thereof.
- 4. Compound of claim 3 which is 5-butyl-1-[(2'-carboxybiphenyl-4-yl) methyl]-1,2,3-triazole, or a pharmaceutically suitable salt thereof.
- 5. A pharmaceutical composition comprising a pharmaceutically suitable carrier and a compound of claim 1, claim 2 or claim 3.
CROSS REFERENCE TO RELATED APPLICATIONS
This is a division of application Ser. No. 07/498,938, filed Mar. 26, 1990, now U.S. Pat. No. 5,081,727 which is a divisional of U.S. Ser. No., 07/279,193, field Dec. 6, 1988, now U.S. Pat. No. 5,015,651 which is a continuation-in-part of U.S. application Ser. No. 07/141,669, filed Jan. 7, 1988, now abandoned.
US Referenced Citations (13)
Foreign Referenced Citations (7)
Number |
Date |
Country |
103647 |
Mar 1984 |
EPX |
165777 |
Dec 1985 |
EPX |
253310 |
Jan 1988 |
EPX |
49042658 |
Aug 1972 |
JPX |
4901372 |
Feb 1973 |
JPX |
57-9771 |
Jan 1982 |
JPX |
1018941A |
May 1983 |
SUX |
Non-Patent Literature Citations (2)
Entry |
Pals, et al., Cir. Res., 29, 673 (1971). |
Streeten & Anderson, Handbook of Hypertension, vol. 5, Clinical Pharmacology of Antihypertensive Drugs, A. E. Doyle (Ed.) Elsevier Sci. Publ. BV., p. 246 |
Divisions (2)
|
Number |
Date |
Country |
Parent |
498938 |
Mar 1990 |
|
Parent |
279193 |
Dec 1988 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
141669 |
Jan 1988 |
|